PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.13
ESG score 80-90% of ADAP's 62.74. Walter Schloss would scrutinize governance quality and regulatory exposure.
51.62
Similar environmental score to ADAP's 50.00. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
57.46
Social score below 80% of ADAP's 78.41. Jim Chanos would check for potential social license and litigation risks.
59.31
Similar governance score to ADAP's 59.80. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.